Skip to main content
PACS
NYSE Industrial Applications And Services

PACS Group President & COO Sells Over $1.2M in Stock Amidst Federal Investigations

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$35.7
Mkt Cap
$5.611B
52W Low
$7.5
52W High
$43.08
52W Position info
376% above low
Off High info
17% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

PACS has more than doubled off its 52-week low of $7.5.

Summary

Joshua Jergensen, President & COO of PACS Group, sold 36,335 shares of common stock for approximately $1.25 million, a transaction that occurs while the company faces federal investigations and an adverse audit opinion.


Key Events · Ownership and Investor Activity · PACS

  • Executive Stock Sale

    Joshua Jergensen, President & COO, disposed of 36,335 shares of PACS Group common stock.

  • Significant Transaction Value

    The shares were sold in an open market transaction for a total value of approximately $1,245,647 at an average price of $34.28 per share.

  • Context of Ongoing Investigations

    This sale occurs as PACS Group is under federal investigation by the DOJ and SEC for alleged fraud and has received an adverse audit opinion on internal controls, as disclosed in its recent 10-K.


Analysis · PACS · Industrial Applications And Services

This Form 4 filing reports a significant open market sale by a key executive, the President and COO, Joshua Jergensen. While the sale represents a small percentage of the company's overall market capitalization, the absolute value of over $1.2 million is substantial. This transaction is particularly notable given the company's recent disclosure of ongoing federal investigations by the DOJ and SEC into alleged fraud, as well as an adverse audit opinion on internal controls. An insider sale during such a period of heightened scrutiny could be interpreted by investors as a lack of confidence or a move to reduce personal exposure to potential risks.

At the time of this filing, PACS was trading at $35.70 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $5.6B. The 52-week trading range was $7.50 to $43.08. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PACS - Latest Insights

PACS
Jul 06, 2026, 4:51 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $45.00
Real-time Price: $46.44 info
Change: +$1.44 (+3%) info
Market Cap: $7.35B info
PACS
Jun 29, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $39.94
Real-time Price: $46.44 info
Change: +$6.50 (+16%) info
Market Cap: $7.35B info
PACS
Jun 26, 2026, 2:22 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $41.18
Real-time Price: $46.44 info
Change: +$5.26 (+13%) info
Market Cap: $7.35B info
PACS
May 11, 2026, 4:18 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $37.98
Real-time Price: $46.44 info
Change: +$8.46 (+22%) info
Market Cap: $7.35B info
PACS
May 11, 2026, 4:17 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $37.98
Real-time Price: $46.44 info
Change: +$8.46 (+22%) info
Market Cap: $7.35B info